
InterCure Ltd. (NASDAQ:INCR) (TSX:INCR) (TASE:INCR) released its financial results for the second quarter of 2022, revealing record revenue of approximately CA$37 million, more than double the revenues of the second quarter of 2021 and representing sequential growth of over 9%.
Q2 2022 and Recent Financial & Operating Highlights